A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy

Nature Medicine

Volumn 15, Issue 1, 2009, Pages 75-83

  Lorenz, Kristina ^a   Schmitt, Joachim P ^a   Schmitteckert, Eva M ^a,b   Lohse, Martin J ^a,b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN GAMMA SUBUNIT; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; RAF PROTEIN; THREONINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHOSPHORYLATION; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVATION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; GENE MUTATION; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN SECRETION;

MUS; MUS MUSCULUS;

EID: 58149351369     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.1893     Document Type: Article

References (47)

1. Sugden, P.H. & Clerk, A. Cellular mechanisms of cardiac hypertrophy. J. Mol. Med. 76, 725-746 (1998).
2. 11 in cardiomyocytes. Nat. Med. 7, 1236-1240 (2001).
3. Lips, D.J., deWindt, L.J. & van Kraaij, D.J.W. & Doevendans, P.A. Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy. Eur. Heart J. 24, 883-896 (2003).
4. Muslin, A.J. Role of Raf proteins in cardiac hypertrophy and cardiomyocyte survival. Trends Cardiovasc. Med. 15, 225-229 (2005).
5. Glennon, P.E. et al. Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes. Circ. Res. 78, 954-961 (1996).
6. Bueno, O.F. et al. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J. 19, 6341-6350 (2000).
7. Takeishi, Y. et al. Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: comparison with acute mechanical stress. J. Mol. Cell. Cardiol. 33, 1637-1648 (2001).
8. Haq, S. et al. Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure. Circulation 103, 670-677 (2001).
9. Purcell, N.H. et al. Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo. Proc. Natl. Acad. Sci. USA 104, 14074-14079 (2007).
10. mapk. Proc. Natl. Acad. Sci. USA 89, 5779-5783 (1992).
11. Seger, R. & Krebs, E.G. The MAPK signalling cascade. FASEB J. 9, 726-735 (1995).
12. Luttrell, L.M. 'Location, location, location': activation and targeting of MAP kinases by G protein-coupled receptors. J. Mol. Endocrinol. 30, 117-126 (2003).
13. Caunt, C.J., Finch, A.R., Sedgley, K.R. & McArdle, C.A. Seven-transmembrane receptor signalling and ERK compartmentalization. Trends Endocrinol. Metab. 17, 276-283 (2006).
14. Torii, S., Nakayama, K., Yamamoto, T. & Nishida, E. Regulatory mechanisms and function of ERK MAP kinases. J. Biochem. 136, 557-561 (2004).
15. Tohgo, A. et al. The stability of the G protein-coupled receptor-β-arrestin interaction determines the mechanism and functional consequence of ERK activation. J. Biol. Chem. 278, 6258-6267 (2003).
16. Crespo, P., Xu, N., Simonds, W.F. & Gutkind, J.S. Ras-dependent activation of MAP kinase pathway mediated by G-protein βγ subunits. Nature 369, 418-420 (1994).
17. Slupsky, J.R. et al. Binding of Gβγ subunits to cRaf1 downregulates G protein-coupled receptor signalling. Curr. Biol. 9, 971-974 (1999).
18. Faure, M., Voyno-Yasenetskaya, T.A. & Bourne, H.R. cAMP and βγ subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J. Biol. Chem. 269, 7851-7854 (1994).
19. Schwindinger, W.F. & Robishaw, J.D. Heterotrimeric G protein βγ dimers in growth and differentiation. Oncogene 20, 1653-1660 (2001).
20. Tachibana, H., Naga Prasad, S.V., Lefkowitz, R.J., Koch, W.J. & Rockman, H.A. Level of β-adrenergic receptor kinase 1 inhibition determines degree of cardiac dysfunction after chronic pressure overload-induced heart failure. Circulation 111, 591-597 (2005).
21. Li, Z. et al. Effects of two Gbg-binding proteins - N-terminally truncated phosducin and β-adrenergic receptor kinase C terminus (βARKct) - in heart failure. Gene Ther. 10, 1354-1361 (2003).
22. Mansour, S.J. et al. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265, 966-970 (1994).
23. Schmitt, J.P. et al. Consequences of pressure overload on sarcomere protein mutation-induced hypertrophic cardiomyopathy. Circulation 108, 1133-1138 (2003).
24. Thomas, W.G. et al. Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor. Circ. Res. 90, 135-142 (2002).
25. Brown, J.H. et al. Pathways and roadblocks in muscarinic receptor-mediated growth regulation. Life Sci. 60, 1077-1084 (1997).
26. q- overexpressing mice. Circulation 97, 1488-1495 (1998).
27. Akhter, S.A. et al. Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science 280, 574-577 (1998).
28. Rohrbach, S. et al. Neuregulin in cardiac hypertrophy in rats with aortic stenosis. Differential expression of erbB2 and erbB4 receptors. Circulation 100, 407-412 (1999).
29. Baliga, R.R. et al. NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK. Am. J. Physiol. 277, H2026-H2037 (1999).
30. Lorenz, K., Lohse, M.J. & Quitterer, U. Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 426, 574-579 (2003).
31. q/11 through tyrosine phosphorylation of the α subunit. Science 276, 1878-1881 (1997).
32. 3 muscarinic acetylcholine receptor-mediated signaling is regulated by distinct mechanisms. Mol. Pharmacol. 74, 338-347 (2008).
33. Khokhlatchev, A.V. et al. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell 93, 605-615 (1998).
34. Hartkamp, J., Troppmair, J. & Rapp, U.R. The JNK/SAPK activator mixed lineage kinase 3 (MLK3) transforms NIH 3T3 cells in a MEK-dependent fashion. Cancer. Res. 59, 2195-2202 (1999).
35. Bogoyevitch, M.A. & Sudgen, P.H. The role of protein kinases in adaptational growth of the heart. Int. J. Biochem. Cell. Biol. 28, 1-12 (1996).
36. Bueno, O.F. & Molkentin, J.D. Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ. Res. 91, 776-781 (2002).
37. Zhong, W. et al. Hypertrophic growth in cardiac myocytes is mediated by Myc through a cyclin D2-dependent pathway. EMBO J. 25, 3869-3879 (2006).
38. Markou, T., Hadzopoulou-Cladarasb, M. & Lazou, A. Phenylephrine induces activation of CREB in adult rat cardiac myocytes through MSK1 and PKA signaling pathways. J. Mol. Cell. Cardiol. 37, 1001-1011 (2004).
39. Valks, D.M. et al. Phenylephrine promotes phosphorylation of Bad in cardiac myocytes through the extracellular signal-regulated kinases 1/2 and protein kinase A. J. Mol. Cell. Cardiol. 34, 749-763 (2002).
40. Dorn, G.W. II & Force, T. Protein kinase cascades in regulation of cardiac hypertrophy. J. Clin. Invest. 115, 527-537 (2005).
41. Garrington, T.P. & Johnson, G.L. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 11, 211-218 (1999).
42. Chang, L. & Karin, M. Mammalian MAP kinase signalling cascades. Nature 410, 37-40 (2001).
43. Pouysségur, J., Volmat, V. & Lenormand, P. Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Biochem. Pharmacol. 64, 755-763 (2002).
44. Brunet, A. et al. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J. 18, 664-674 (1999).
45. Cobb, M.H. & Goldsmith, E.J. Dimerization in MAP kinase signaling. Trends Biochem. Sci. 25, 7-9 (2000).
46. Müller, S., Heckman, M. & Lohse, M.J. Specific enhancement of β-adrenergic receptor kinase activity by defined Gβ and Gγ subunits. Proc. Natl. Acad. Sci. USA 90, 10439-10443 (1993).
47. i- specific region. J. Biol. Chem. 280, 24584-24590 (2005).